Relative Strength Chart Viking Therapeutics, Inc.
Equities
VKTX
US92686J1060
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.45 USD | -4.47% |
|
-13.10% | -19.13% |
| 05/06 | Viking Therapeutics, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-04-2026 01:25 PM | |
| 28/05 | Lake Street Initiates Viking Therapeutics With Buy Rating, $89 Price Target | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIKING THERAPEUTICS, INC. | Bio Therapeutic Drugs | -4.47% | -13.10% | -19.13% | +2.23% | +440.87% | 330.32Cr |  | | |
- Stock Market
- Equities
- VKTX Stock
- Charts Viking Therapeutics, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition